Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects - PubMed (original) (raw)
Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects
L J Dominguez et al. J Clin Endocrinol Metab. 1998 Dec.
Abstract
Depletion of intracellular free magnesium (Mg(i)) is a characteristic feature of insulin resistance in essential hypertension, but it is not clear to what extent low Mg(i) levels contribute to insulin resistance, result from it, or both. As insulin-like growth factor I (IGF-I) may improve insulin resistance, we investigated whether this peptide could similarly improve Mg(i) responsiveness to insulin in hypertension, and whether this effect was related to any direct IGF-I effect on Mg(i). 31P-Nuclear magnetic resonance spectroscopy was used to measure Mg(i) in erythrocytes from 13 fasting normotensive and 10 essential hypertensive subjects before and 30, 60, and 120 min after incubation with a physiologically maximal dose of insulin (200 microU/mL) and with different doses of recombinant human IGF-I (0.1-100 nmol/L). In normotensive subjects, IGF-I elevated Mg(i) (P < 0.05) in a dose- and time-dependent fashion, as did insulin (P < 0.05). However, in hypertensive subjects, maximal Mg(i) responses to insulin, but not to IGF-I, were blunted [insulin, 163+/-11 to 177+/-10 micromol/L (P=NS); IGF-I, 164+/-6 to 190+/-11.7 micromol/L (P < 0.05)]. Furthermore, for insulin, but not for IGF-I, cellular Mg(i) responsiveness was closely and directly related to basal Mg(i) levels (insulin: r=0.72; P < 0.01; IGF-I: r=0.18; P=NS). Lastly, blunted Mg(i) responses to insulin could be reversed by preincubation of hypertensive cells with IGF-I. We conclude that 1) both IGF-I and insulin stimulate erythrocyte Mg(i) levels; 2) cellular Mg(i) responses to insulin, but not to IGF-I, depend on basal Mg(i) levels, i.e. the higher the Mg(i) the greater the sensitivity to insulin; and 3) IGF-I potentiates insulin-induced stimulation of Mg(i) at doses that themselves do not raise Mg(i). These effects of IGF-I may underlie at least in part its ability to improve insulin sensitivity clinically. Together, these data support a role for IGF-I in cellular magnesium metabolism and emphasize the importance of magnesium as a determinant of insulin action.
Similar articles
- Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness.
Barbagallo M, Gupta RK, Bardicef O, Bardicef M, Resnick LM. Barbagallo M, et al. J Clin Endocrinol Metab. 1997 Jun;82(6):1761-5. doi: 10.1210/jcem.82.6.4022. J Clin Endocrinol Metab. 1997. PMID: 9177378 - Insulin-mimetic action of vanadate: role of intracellular magnesium.
Barbagallo M, Dominguez LJ, Resnick LM. Barbagallo M, et al. Hypertension. 2001 Sep;38(3 Pt 2):701-4. doi: 10.1161/hy09t1.095392. Hypertension. 2001. PMID: 11566960 - Altered cellular magnesium responsiveness to hyperglycemia in hypertensive subjects.
Barbagallo M, Dominguez LJ, Bardicef O, Resnick LM. Barbagallo M, et al. Hypertension. 2001 Sep;38(3 Pt 2):612-5. doi: 10.1161/hy09t1.095764. Hypertension. 2001. PMID: 11566941 - Impaired insulin-mediated erythrocyte magnesium accumulation in essential hypertension.
Paolisso G, Passariello N, Sgambato S, Torecca R, Buoninconti R, Varricchio M, D'Onofrio F. Paolisso G, et al. Clin Sci (Lond). 1987 Nov;73(5):535-9. doi: 10.1042/cs0730535. Clin Sci (Lond). 1987. PMID: 3315399 - Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme.
Resnick LM. Resnick LM. J Am Soc Nephrol. 1992 Oct;3(4 Suppl):S78-85. doi: 10.1681/ASN.V34s78. J Am Soc Nephrol. 1992. PMID: 1457764 Review.
Cited by
- The Therapeutic Effects of Magnesium in Insulin Secretion and Insulin Resistance.
Hosseini Dastgerdi A, Ghanbari Rad M, Soltani N. Hosseini Dastgerdi A, et al. Adv Biomed Res. 2022 Jun 29;11:54. doi: 10.4103/abr.abr_366_21. eCollection 2022. Adv Biomed Res. 2022. PMID: 35982863 Free PMC article. Review. - IGF-1, the cross road of the nutritional, inflammatory and hormonal pathways to frailty.
Maggio M, De Vita F, Lauretani F, Buttò V, Bondi G, Cattabiani C, Nouvenne A, Meschi T, Dall'Aglio E, Ceda GP. Maggio M, et al. Nutrients. 2013 Oct 21;5(10):4184-205. doi: 10.3390/nu5104184. Nutrients. 2013. PMID: 24152751 Free PMC article. Review. - Magnesium in disease.
Geiger H, Wanner C. Geiger H, et al. Clin Kidney J. 2012 Feb;5(Suppl 1):i25-i38. doi: 10.1093/ndtplus/sfr165. Clin Kidney J. 2012. PMID: 26069818 Free PMC article. - Analysis of serum magnesium ions in dogs exposed to external stress: A pilot study.
Ando I, Karasawa K, Yokota S, Shioya T, Matsuda H, Tanaka A. Ando I, et al. Open Vet J. 2017;7(4):367-374. doi: 10.4314/ovj.v7i4.13. Epub 2017 Dec 24. Open Vet J. 2017. PMID: 29392116 Free PMC article. - The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients.
ELDerawi WA, Naser IA, Taleb MH, Abutair AS. ELDerawi WA, et al. Nutrients. 2018 Dec 26;11(1):44. doi: 10.3390/nu11010044. Nutrients. 2018. PMID: 30587761 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous